NIAGEN BIOSCIENCE, INC. Financial Asset Purchased Under Agreement To Resell
NIAGEN BIOSCIENCE, INC. (NAGE) had Financial Asset Purchased Under Agreement To Resell of $6.00 million as of 2026-02-24, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:FinancialAssetPurchasedUnderAgreementToResell · last filed 2026-08-04
- 2026-02-24: Financial Asset Purchased Under Agreement To Resell $6.00M.
| Period end | Financial Asset Purchased Under Agreement To Resell |
|---|---|
| 2026-02-24 | $6.00M 10-Q · filed 2026-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |